Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 2 | US | 17 Nov 2021 | |
Breast Cancer | Phase 2 | US | 17 Nov 2021 | |
Central nervous system injury | Phase 2 | US | 17 Nov 2021 | |
Disorder related to transplantation | Phase 2 | US | 17 Nov 2021 | |
Non-Small Cell Lung Cancer | Phase 2 | US | 17 Nov 2021 | |
Parkinson Disease | Phase 2 | US | 17 Nov 2021 | |
Prostatic Cancer | Phase 2 | US | 17 Nov 2021 | |
Psoriasis | Phase 2 | US | 17 Nov 2021 | |
Rheumatoid Arthritis | Phase 2 | US | 17 Nov 2021 | |
Schizophrenia | Phase 2 | US | 17 Nov 2021 |